How do we feel about this study (DAPA advKD)?
https://www.medscape.com/viewarticle/dapagliflozin-safe-and-effective-ckd-stages-4-and-5-2024a1000jm4?&icd=login_success_email_match_fpf
Does it answer the Q of initiating SGLT2-I in adv CKD? Are the numbers enough?
#nephsky @kidneyboy.bsky.social @hswapnil.bsky.social @freelyfiltered.bsky.social
Maybe another one that could be discussed..
https://www.medscape.com/viewarticle/dapagliflozin-safe-and-effective-ckd-stages-4-and-5-2024a1000jm4?&icd=login_success_email_match_fpf
Does it answer the Q of initiating SGLT2-I in adv CKD? Are the numbers enough?
#nephsky @kidneyboy.bsky.social @hswapnil.bsky.social @freelyfiltered.bsky.social
Maybe another one that could be discussed..
Comments
But it’s not surprising - even in long term EMPAKIDNEY http://www.nephjc.com/news/empa-long-term around 35% had GFR < 30
Until then - never stop the Flozin!
Pic from @sarahsanghavi.bsky.social
- ‘this new agent reduces albuminuria in IgA Nephropathy’ is another suggestion 😏